Baxdrostat Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Japanese Population
Clinical trial NCT05966324 · COMPLETED
Trial details
- NCT number
- NCT05966324
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-05
- Primary completion
- 2022-09-20
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.